Crypto Whales Buy Chainlink (LINK) – How Does This Affect Price?
According to on-chain analytics platform Lookonchain, institutional investors and whales have accumulated Chainlink (LINK) over the past week.
Report as of July 2 revealed that 54 new wallets have collectively withdrawn 2.08 million LINK, worth approximately $30.3 million, from Binance over the past seven days.
The price of LINK suffered a decline during the June market pullback, hitting a monthly low of $13 on June 24. However chainlink the ecosystem continues to grow.
On July 1st, the Chainlink team reported for 12 integrations of six of their services on eight different blockchains.
READ MORE:
Positive outlook for Cardano price in JulyIt was too reported , that Chainlink has risen to the top spot in terms of development activity. The ranking was based on the significant events recorded, with Chainlink receiving a score of 560.6 points.
Alongside these events, Coinbase submitted application to include LINK in the list of futures contracts with the Commodity Futures Trading Commission (CFTC).
At the time of writing, Chainlink is trading at $14.58, up 5% over the past week.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Qualcomm (QCOM.US) Snapdragon Summit Preview: 2nm Dual-Chip Debuts, AI Diversification Narrative Faces Key Verification
Qualcomm is scheduled to hold its annual Snapdragon Summit in Maui, Hawaii, from September 22 to 24 local time.
SUI SuperTrend Flips to Buy — Macro Shift From Bearish to Bullish Begins

Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"
After being surpassed by Eli Lilly in the obesity market, Novo Nordisk failed to present a concrete turnaround plan to CEO Mike Doustdal, disappointing investors. The company has pledged to launch more than five blockbuster drugs in the coming years and achieve over $23 billion in new sales, but the press conference lacked details on how to drive growth.

STONK hits new highs after erasing 27% crash
